BALTIMORE (Stockpickr) --�Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating investment ideas. Instead, let the crowd do it for you.
>>5 Hated Earnings Stocks You Should Love
From hedge funds to individual investors, scores of market participants are turning to social media to figure out which stocks are worth watching. It's a concept that's known as "crowdsourcing," and it uses the masses to identify emerging trends in the market.
Crowdsourcing has long been a popular tool for the advertising industry, but it also makes a lot of sense as an investment tool. After all, the market is completely driven by the supply and demand, so it can be valuable to see what names are trending among the crowd.
While some fund managers are already trying to leverage social media resources like Twitter to find algorithmic trading opportunities, for most investors, crowdsourcing works best as a starting point for investors who want a starting point in their analysis. Today, we'll leverage the power of the crowd to take a look at some of the most active stocks on the market today.
Top 5 Managed Healthcare Stocks To Own For 2014: Pacific Drilling SA (PACD)
Pacific Drilling S.A., incorporated on March 22, 2011, is an international offshore drilling Company. The Company is a provider of ultra-deepwater drilling services to the oil and natural gas industry through the use of high-specification drilling rigs. The Company�� primary business is to contract its ultra-deepwater drilling rigs, related equipment and work crews, primarily on a dayrate basis, to drill wells for its customers. The Company is primarily focused on the ultra-deepwater market. The Company generally consider ultra-deepwater to begin at water depths of more than 7,500 feet and to extend to the maximum water depths, in which rigs are capable of drilling, which is approximately 12,000 feet.
The Company operates four drillships and has four drillships under construction, two of which are under customer contract. In connection with the Restructuring, the Company�� Predecessor was contributed to a wholly owned subsidiary of the Company by a subsidiary of Quantum Pacific International Limited.
Advisors' Opinion: - [By Aaron Levitt]
Management recently announced a hefty 50% hike in its quarterly dividend to 37.5 cents per share of NE stock. And with a 4.8% dividend yield, NE stock is now one of the best-paying dividend stocks in the energy sector.
Dividend Stocks To Buy #5 — Pacific Drilling (PACD) Estimated Dividend Yield: 6.5%
- [By Roberto Pedone]
Pacific Drilling (PACD) is an international offshore drilling contractor committed to becoming the preferred provider of ultra-deepwater drilling services to the oil and natural gas industry through the use of high-specification rigs. This stock closed up 1% to $9.94 in Thursday's trading session.
Thursday's Range: $9.87-$10.00
52-Week Range: $8.63-$10.99
Thursday's Volume: 450,000
Three-Month Average Volume: 308,772
From a technical perspective, PACD bounced modestly higher here right above its 50-day moving average of $9.67 with above-average volume. This stock has been trending sideways and consolidating for the last five months, with shares moving between $8.89 on the downside and $10.23 on the upside. Shares of PACD are now starting to trend within range of triggering a breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if PACD manages to take out some key overhead resistance levels at $10.14 to $10.23 with high volume.
Traders should now look for long-biased trades in PACD as long as it's trending above its 50-day at $9.81 and then once it sustains a move or close above those breakout levels with volume that hits near or above 308,772 shares. If that breakout triggers soon, then PACD will set up to re-test or possibly take out its next major overhead resistance levels at $10.71 to its 52-week high at $10.99. Any high-volume move above $10.99 will then put its all-time high at $11.47 within range for shares of PACD.
- [By David Smith]
Chevron has been working hand-in-glove in implementing DGD with offshore rig operator Pacific Drilling (NYSE: PACD ) . Pacific's drillship Pacific Santa Ana was specifically built to Chevron's DGD-enhancing specifications and is working for the big company in the Gulf of Mexico.
Top 5 Managed Healthcare Stocks To Own For 2014: Ellie Mae Inc (ELLI)
Ellie Mae, Inc., incorporated October 14, 2007, is a provider of on-demand automation solutions for the mortgage industry. The Company offers an end-to-end solution, delivered using a Software-as-a-Service model that serves as the core operating system for mortgage originators and spans customer relationship management, loan origination and business management. It also hosts the Ellie Mae Network that allows Encompass users to electronically conduct business transactions with the lenders and settlement service providers they work with to process and fund loans. The Company's offerings include range of Encompass services and the DataTrac mortgage management software system. On August 15, 2011, it completed the acquisition of Del Mar Datatrac,Inc. (DMD).
Using the Company�� network technology, it has helped connect a fragmented world of mortgage bankers, mortgage brokers, community banks, credit unions, lenders, investors and service providers, all of which are integral to the origination and funding of residential mortgages. Its Encompass360 solutions include Encompass Product & Pricing Service; Ellie Mae Total Quality Loan Program; Encompass Compliance Service; Encompass Appraisal Service; Encompass CenterWise; Encompass Commissions; Encompass TPO WebCenter and Encompass Docs Solution.
Ellie Mae�� Total Quality Loan program helps in identifying compliance, income and fraud issues early in the origination process; help protect business from loan buy-backs, and fortify workflow and uncover and correct possible issues before you close the loan.Encompass Appraisal Service, integrated inside Encompass360, is that solution helps in completing order right from the loan file in Encompass360; import complete appraisal reports directly into eFolder, and customize appraisal workflow by type of loan and control, which its users can order appraisals. Its Encompass CenterWise wraps two essential Web and electronic document solutions into one unified package. Encompass Commissions is a ! commission management solution integrated inside Encompass360 that automates the calculation, reconciliation and communication of variable pay across your organization. Hosted Encompass360 Banker Edition users can connect directly with third-party originators (TPOs) without leaving Encompass360, and have them connect back in a secure, synchronized, and easy-to-use Web-based environment. Encompass Docs Solution provides a single, integrated application incorporating both initial disclosures and closing documents.
Advisors' Opinion: - [By SA Pro Top Ideas]
Stock Movers and Great Calls
Alpha-Rich long and short ideas regularly move stocks and identify stocks that are about to move. Some notable recent calls subscribers had early access to:
Saidal Mohmand argued Wednesday that Tellabs (TLAB) was a strong assets play on the verge of a turnaround. The stock is +5.9% since. Read article » On June 13, Stephen Lin said that Ellie Mae's (ELLI) dominant position could mean 45% upside. Shares are +30.7% since. Read article » To Come Today
Don't forget to check your SA Pro dashboard later today for the latest Alpha-Rich ideas, including a REIT with strong management and many catalysts. Any thoughts to share on the latest Alpha-Rich ideas? Leave a comment here. Have a great weekend.
SA Pro Editors
…............
The SA Pro team is Eli Hoffmann (Editor in Chief), Rachael Granby (Editorial Product Manager), Daniel Shvartsman, Samir Patel, Michael McDonald, and Jeffrey Fischer (Senior Pro Editors). You can reach us at pro-editors@seekingalpha.com.
- [By Simon Erickson]
Rule Breakers analyst Simon Erickson believes Ellie Mae (NYSE: ELLI ) , an innovator in the mortgage industry, could be in a perfect place to capitalize on the situation. In the video below, he presents three reasons he thinks the stock is a buy today.
Receptos, Inc. (Receptos), incorporated on June 9, 2008, is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing therapeutics for immune disorders. The Company�� product candidates span three specialty disease areas. The Company�� lead asset, RPC1063, is being developed as an oral therapy for the treatment of relapsing multiple sclerosis (RMS) and inflammatory bowel disease (IBD). Its second asset, RPC4046, is being developed for the treatment of an allergic/immune-mediated disorder, eosinophilic esophagitis (EoE), which is an orphan disease. RPC1063 is an oral, once daily, selective and potent sphingosine 1-phosphate 1 receptor (S1P1R) modulator. RPC4046 is a monoclonal antibody selective to interleukin-13 (IL-13) and produced by recombinant deoxyribonucleic acid (DNA) technology.
As of December 31, 2012, RPC1063 was being tested in the Phase II portion of an accelerated design, randomized Phase II/III study for the treatment of RMS. In addition, Receptos has obtained special protocol assessment (SPA) agreement from the United States food and drug administration (FDA) on its clinical trial design for the planned Phase III portion of the Phase II/III study, as well as a second planned RMS Phase III study. RPC1063 is also being tested in a randomized Phase II study for the treatment of ulcerative colitis (UC), a gastrointestinal (GI) disea se.
As of December 31, 2012, the Company was enrolling a randomized Phase II study evaluating the ability of RPC1063 to induce clinical remission in patients with moderately-to-severely active UC called TOUCHSTONE. The Company�� second asset, RPC4046 for the treatment of EoE, builds upon its competencies in immunology and GI diseases. In-licensed from AbbVie Bahamas Ltd. and AbbVie Inc. (AbbVie) RPC4046 is a monoclonal antibody directed against the IL-13 target, which has been validated in Asthma, a predominantly allergic/immune-mediated disorder.
Advisors' Opinion: - [By Roberto Pedone]
Receptos (RCPT) is a biopharmaceutical company engaged in discovering, developing and commercializing therapeutics for immune disorders. This stock closed up 5% at $23.19 in Monday's trading session.
Monday's Volume: 69,000
Three-Month Average Volume: 55,356
Volume % Change: 50%
From a technical perspective, RCPT ripped higher here right above some key near-term support at $21 with decent upside volume. This move is quickly pushing shares of RCPT within range of triggering a major breakout trade. That trade will hit if RCPT manages to take out its all-time high at $25 with high volume.
Traders should now look for long-biased trades in RCPT as long as it's trending above support at $21 and then once it sustains a move or close above its all-time high at $25 with volume that's near or above 55,356 shares. If that breakout hits soon, then RCPT will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $30 to $35.
- [By John Udovich]
Small cap �biopharmaceutical stock Receptos Inc (NASDAQ: RCPT) was one of the many hot biotech IPOs of last year and its also up 72.4% since the start of this year alone, meaning its time to take a closer look at this small cap stock with potential treatments for Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD) along with the performance of biotech ETF benchmarks like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
Top 5 Managed Healthcare Stocks To Own For 2014: IFM Investments Ltd (CTC)
IFM Investments Limited, incorporated on November 30, 2005, is a real estate services provider with the network of real estate sales offices in People�� Republic of China. The Company is the exclusive franchisor in People�� Republic of China for the CENTURY 21 brand As of December 31, 2012, its CENTURY 21 China network covered 27 cities. The Company operates under four business lines: Company-owned brokerage services, Primary and commercial services, mortgage management services and franchise services. As of December 31, 2012, the Company had approximately 321 Company-owned sales offices, representing approximately 34.7% of its CENTURY 21 China network. Its Company-owned brokerage services business owns and operates regional sub-franchisors and sales offices in the CENTURY 21 China network. The Company�� mortgage management services business provides mortgage advisory services to home buyers and home owners and interim guarantee services to commercial banks.
Company-owned Brokerage Services
As of December 31, 2012, the Company directly owns 318 CENTURY 21 sales offices located in Beijing, Shanghai and Shenzhen, cities in People�� Republic of China with a number of secondary market real estate transactions per year. Through its Company-owned brokerage services business, the Company participates in sales and leasing transactions primarily with respect to middle to high grade residential properties in the secondary real estate market. Its services include property listing, advisory services and transaction negotiation and documentation. The Company also promotes its mortgage management services to its customers to provide real estate brokerage services. It also participates in real estate sales and leasing transactions with respect to properties in the primary and commercial real estate markets. The Company operates its Company-owned brokerage services business under the CENTURY 21franchise network.
The Company competes with Centaline (China) Property Cons! ultants Limited Shanghai, Shenzhen and Chengdu.
Primary and commercial services
The Company�� primary and commercial services business consists of two business units, one that provides agency services to primary residential real estate developers and one that provides planning, consulting and brokerage services to commercial property developers. The Company generates revenues from its primary services by earning sales commissions from primary residential property developer clients, and it generate revenues from its commercial services by collecting service fees for consultancy services provided to commercial property developers.
The Company competes with World Union Properties Consulting Co., Limited and Syswin Inc., E-House (China) Holdings Limited, CB Richard Ellis and Jones Lang Lasalle.
Mortgage Management Services
The Company operates its mortgage management services as a separate segment under the brand of Kaisheng. Its mortgage management services include advisory services in connection with the selection and procurement of mortgage products offered by commercial banks. Its mortgage consultants promote and introduce various mortgage products, and advise home buyers or home owners in the selection of the appropriate mortgage product based on each mortgagor�� individual needs. The Company also has a call center in Shanghai to promote its mortgage management services business directly to its customers. The Company also provides mortgage management services to customers outside of its CENTURY 21 China network.
The Company competes with Beijing Houze Investment, Guarantee Company Limited and Shanghai Haoyonghang Investment Management Company Limited.
Franchise Services
The Company�� franchise network consists of three levels of franchise rights. First, through IFM Company Limited (IFM Co.), its wholly owned subsidiary, the Company is the exclusive franchisor for the CENTURY 21 brand in China. ! IFM Co. i! n-turn grants the right to franchise the CENTURY 21 brand within specific geographical regions to sub-franchisors whom the Company refers to as regional sub-franchisors. As of December 31, 2012, the Company had 25 regional sub-franchisors with franchise networks in 27 cities in People�� Republic of China with a total of 924 franchised sales offices. Second, each regional sub-franchisor pays the Company ongoing service fees based on its revenue from the sales offices within its respective region, subject to minimum service fee requirements. In addition to generating revenue from its regional sub-franchisors, the Company leverages the geographic breadth and local market expertise of its CENTURY 21 franchise network.
The Company competes with Coldwell Banker.
Advisors' Opinion: Top 5 Managed Healthcare Stocks To Own For 2014: United Continental Holdings Inc.(UAL)
United Continental Holdings, Inc., through its subsidiaries, engages in the provision of passenger and cargo air transportation services. As of February 24, 2011, it operated a total of approximately 5,675 flights a day to 372 airports on 6 continents from their hubs in Chicago, Cleveland, Denver, Guam, Houston, Los Angeles, New York, San Francisco, and Tokyo, as well as in Washington, D.C. The company was formerly known as UAL Corporation and changed its name to United Continental Holdings, Inc. on October 1, 2010. United Continental Holdings, Inc. was founded in 1934 and is headquartered in Chicago, Illinois.
Advisors' Opinion: - [By Sean Williams]
At 11 times forward earnings, Southwest isn't particularly expensive, but it's also in the process of fully integrating AirTran, which it purchased two years ago. There are innumerable benefits to Southwest's purchase, including international exposure that it previously didn't have; a hub in the world's largest airport, Atlanta-Hartsfeld; and access to busy metropolises. Then again, mergers and acquisitions in the airline space don't always go as planned. United and Continental merged to create United Continental Holdings (NYSE: UAL ) in 2010 to realize synergies, reduce expenses, and better compete against the nation's largest airlines. However, last year the merger actually resulted in more costs, not less, for United!
- [By Adam Levine-Weinberg]
For that reason, Delta Air Lines (NYSE: DAL ) announced a plan last year to reduce its 50-seat regional jet fleet to no more than 125 aircraft by the end of 2015, down from a high of 550 planes in 2008 and 2009. It is replacing that capacity with larger regional jets (mostly seating 76 passengers) and small mainline aircraft (110 seats). United Continental (NYSE: UAL ) is also replacing many of its 50-seat jets with larger regional jets, although it remains well behind Delta in that process.
- [By Lisa Levin]
Analysts at JP Morgan downgraded United Continental Holdings (NYSE: UAL) from ��eutral��to ��nderweight.��The target price for United Continental Holdings has been lowered from $32.50 to $25.
- [By Rich Smith]
It wasn't as big as the Boeing 314, with a smaller wingspan and a shorter range. Yet Boeing modestly calls the DC-3, first flown in 1935, "the greatest airplane of its time," and perhaps "the greatest of all time." Many people agree. Originally built for American Airlines (now US Airways (NYSE: LCC ) ), the plane soon gained a fan in United Airlines (now United Continental (NYSE: UAL ) ) -- and then it went on to win sales contracts at nearly three dozen airlines and to (in alliance with its DC-2 predecessor) capture more than 90% of the air-passenger market. The DC-3 carried 28 passengers, or slept 14, which doesn't sound like a lot in today's terms. But it was the first plane capable of carrying enough passengers, and carrying them fuel-efficiently enough, to earn its airline owners a profit.